Pharma Insights & Market Research AI Data

Pharma market research data for AI, from real HCPs and patients.

We supply the verified physician and patient data that builds, calibrates and validates AI personas, so phase zero research is decision-grade.

Request a sample datasetSchedule a conversation

What is pharma market research data for AI?

Pharma market research data for AI is real input from verified physicians, other HCPs and patients. It is used to build, calibrate and validate synthetic personas and simulated panels. It includes structured interviews, survey responses, segment profiles and benchmark answers from fielded studies. Acumen recruits, verifies and documents every respondent so phase zero research holds up.

The challenge

Why can't synthetic personas run on generic data?

Pharma teams now use synthetic personas, also called digital twins, to pressure-test messages and concepts before fielding a study (ZoomRx). Takeda worked with Lumanity to bring its segmentation to life through synthetic personas (pharmaphorum, 2026). These outputs shape launch messaging and segment strategy. They have to be right.

Most personas are built on a model's general knowledge, scraped web text or old study decks. They answer confidently, and nobody can say whose voice they represent. The gap shows up late, when the fielded study disagrees with the persona and the brand plan is already written.

A persona is only as credible as the people behind it.

Expert-led data

Real HCP and patient voices as the foundation, not a footnote.

The questions insights and procurement leads ask before they trust a persona:

  1. How do we validate a synthetic HCP persona before it informs a decision?
  2. Where does the persona's data come from, and who vetted it?
  3. Can we compare AI answers against a real, matched panel?
  4. How does this fit our compliance and adverse-event rules?
  5. What does it cost per study, and when is it cheaper than going to field?
Expertise

From modeled opinions to verified voices.

A persona trained on generic data averages everyone. It sounds like an oncologist without the oncologist's practice setting, payer mix or prescribing habits. Smooth answers hide the segment differences that matter.

We recruit credential-checked HCPs and screened patients by specialty, segment and market. Every input is tagged to a real respondent.

This enables something off-the-shelf personas cannot: persona outputs you can trace to real people.

De-risking

How do you make phase zero research decision-grade?

Phase zero research filters ideas before real HCP and patient fieldwork (Pedowitz). ZS draws a useful line: AI personas explore the why, while validated simulated panels produce decision-grade, quantitative outputs. Validation is what gets you from one to the other. We give teams four ways to get there:

Grounding data

structured interviews and surveys from verified HCPs and patients, by segment

Calibration sets

real panel answers to the same questions, used to tune persona behavior

Validation against fielded studies

side-by-side comparison of persona and panel, scored on rubrics written by practicing physicians

Expert output review

HCPs flag persona answers that don't match how their specialty actually thinks and prescribes

Synthetic research moves from a clever demo to a validated, expert-grounded method.

Continuous data

From one calibration study to a living persona.

Markets move. A competitor launches. A trial reads out. Guidelines and labels change. A persona calibrated last year is answering for a market that no longer exists. The questions keep coming:

  1. Does the persona still reflect HCPs after the latest competitor launch or data readout?
  2. Which segments have drifted furthest from fielded results?
  3. Are we covering the markets and specialties our brand teams need next?
  4. Where do we need fresh patient voice to keep the persona honest?

We answer them with verified HCP and patient data on a recurring cadence, so every persona refresh is grounded.

The reality

Off-the-shelf personas are fast, but unproven.

  1. Built on model priors and public text, not on your target HCPs
  2. No record of who the persona represents or how inputs were vetted
  3. Thin or missing coverage of niche specialties, rare disease patients and smaller markets
  4. Rarely checked against a matched real panel before use
  5. Hard to defend to brand, medical, compliance and procurement reviewers

Generating answers is easy. Grounding them in real HCPs is not.

Expert data, on demand

How Acumen delivers persona data you can stand behind.

  1. Credential-verified HCPs and screened patients, recruited by specialty, segment and market
  2. Matched validation panels with agreement reporting
  3. Physician-written rubrics to score persona answers question by question
  4. Adverse event handling, consent for AI use and de-identification built into fieldwork
  5. Delivered in formats your persona platform can use (JSONL, CSV, coded transcripts, segment specs)

From unverified personas → a validated simulated panel.

Compare

Acumen vs. crowdsourced data vs. in-house persona builds

Acumen expert dataCrowdsourced or scraped dataIn-house build from past studies
Source of persona inputsVerified HCPs and patients recruited for your studyGeneric respondents, web text, model priorsYour historical PMR decks and transcripts
Who is verifiedLicense, specialty and practice setting for HCPs; diagnosis and treatment screening for patientsRarely verifiedVerified at the time of the original study
Segment and market coverageMatched to your segmentation, per taskBroad but shallowLimited to past study scope
Validation against a real panelBuilt in, with agreement reporting by segmentNot includedPossible but slow to field
Compliance and adverse eventsAE reporting, consent for AI use, de-identificationUnclearOriginal consent may not cover AI use
FreshnessRecurring refresh cadenceStaticAges with each market event
Defensible in RFP and stakeholder reviewYes, with provenance trailRarelyPartly
Trust

Persona outputs you can defend to brand, medical and procurement.

Every input carries its provenance: who gave it, their specialty or patient profile, the segment they represent and when they were fielded. Regulators already treat data as evidence for AI. FDA's January 2025 draft guidance on AI-enabled device software asks sponsors to describe data collection, processing and test-data independence. Market research is not a medical device, but procurement now asks the same question: where did the data come from?

We package the answer with documentation ready for medical, legal, compliance and procurement review. Your persona clears internal scrutiny as fast as it answers questions.

The shift.

Models are abundant. Internal LLM platforms are now standard at the top 50 pharma companies (Consilience Strategy, 2026). The AI data market has moved from cheap generic labeling to expert review (Sacra). In pharma insights, the advantage comes from data that reflects the people who prescribe, treat and live with the condition.

Acumen is the expert data layer for building, calibrating and validating AI personas in pharma market research.

THE ENGAGEMENT

Pilot persona study.
Validated against real HCPs.

Scoping call, persona spec and segment plan

Grounding and calibration data: verified HCP and patient respondents

Validation report: persona vs. matched panel, by question and segment

Scale to new segments, markets and a refresh cadence

Request a sample dataset

Pharma market research data for AI: frequently asked questions

What is pharma market research data for AI?

It is primary research input from verified HCPs and patients, structured to build, calibrate and validate AI personas and simulated panels. It includes interview transcripts, survey responses, segment profiles and side-by-side comparisons with fielded studies. Acumen recruits and verifies every respondent, documents provenance and delivers the data in formats your persona platform can use.

How do you validate synthetic HCP personas?

We field the same questions to a verified HCP panel and the persona, then compare the answers by segment. Physicians write rubrics to score whether persona responses reflect real clinical and prescribing logic, the same rubric approach OpenAI's HealthBench used for model evaluation. You get a validation report showing where the persona matches the panel and where it drifts.

Where does the persona's data come from, and how is it vetted?

It comes from HCPs and patients we recruit for your study. We check each HCP's license, specialty and practice setting, and screen patients against your diagnosis and treatment criteria. Every response carries metadata on who gave it and which segment they represent, so you can trace any persona attribute back to real, consented input rather than model guesswork.

Can we compare AI persona answers against a real panel?

Yes. That is the core of validation. We run a matched panel of verified respondents on your discussion guide or survey, then report agreement with the persona by question, segment and market. Use it to set a confidence threshold before persona outputs inform message testing, concept testing or segmentation decisions.

How does this fit our compliance and adverse-event rules?

We follow your pharmacovigilance procedures. Fieldwork includes adverse event identification and reporting on the timelines your safety team sets, and respondent consent covers use of their input to train and validate AI. Patient data is de-identified before it reaches a persona build. Documentation is ready for medical, legal and procurement review.

What does a study cost?

Cost depends on the number of segments, respondents per segment and markets, and on whether you need a refresh cadence. We agree a fixed quote after one scoping call. Pricing covers recruitment, verification, compliance handling and the validation report.

Do synthetic personas replace primary market research?

No. Industry consensus, reflected by Greenbook, Inizio and NIM in 2026, is that synthetic respondents work best alongside primary research and need validation and transparency. Personas are strongest in phase zero: filtering ideas and sharpening hypotheses before real HCP and patient research. Our data keeps that phase grounded and tells you when to go to field.

Do you build the personas or supply the data?

We supply the expert-verified data layer: grounding inputs, calibration sets and validation against real panels. That data plugs into your in-house persona platform, your agency's simulated panel or a vendor tool. We stay independent of the model, so validation results are not graded by the same team that built the persona.

Last updated November 2026

Related pages

Pharma commercial dataMedical affairs & regulatory dataCustom expert data collection